Sun Pharmaceutical Industries Ltd
BSE:524715
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sun Pharmaceutical Industries Ltd
BSE:524715
|
IN |
|
Tokyo Century Corp
TSE:8439
|
JP |
|
N
|
Nexi SpA
F:N0XA
|
IT |
|
M
|
Moody's Corp
XBER:DUT
|
US |
|
Dominion Energy Inc
NYSE:D
|
US |
|
Odfjell Drilling Ltd
OSE:ODL
|
BM |
|
E
|
EBOS Group Ltd
F:EJG
|
AU |
|
O
|
Oracle Corp
XMUN:ORC
|
US |
|
Metro Inc
TSX:MRU
|
CA |
|
HSBC Holdings PLC
LSE:HSBA
|
UK |
|
W
|
WW Grainger Inc
DUS:GWW
|
US |
|
American Lithium Corp
OTC:AMLIF
|
CA |
|
Savannah Resources Plc
LSE:SAV
|
UK |
|
D
|
De La Rue PLC
XBER:DL1C
|
UK |
|
M
|
MGIC Investment Corp
XBER:MGC
|
US |
|
OpGen Inc
NASDAQ:OPGN
|
US |
|
Singapore Airlines Ltd
SGX:C6L
|
SG |
Wall St Price Targets
SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA is 2 086.42 INR with a low forecast of 1 664.54 INR and a high forecast of 2 481.38 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUNPHARMA's stock price target?
Price Target
2 086.42
INR
According to Wall Street analysts, the average 1-year price target for
SUNPHARMA is 2 086.42 INR with a low forecast of 1 664.54 INR and a high forecast of 2 481.38 INR.
What is the Revenue forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 13%.
What is the Gross Profit forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 4 years is 12%.
What is the Operating Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 4 years is 15%.
What is the Pre-Tax Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 4 years is 13%.